Small Molecule API Market
Market Insights on Small Molecule API covering sales outlook, demand forecast & up-to-date key trends
Small Molecule API Market by Molecule Type (Standard API, HPAPI), Production (Captive/In-House, Out Source), Application (Clinical, Commercial), Therapeutic Area & Region - Forecast to 2021-2031
Small Molecule API Market - About the Report
[300 Pages Report] Small molecules are chemical substances composed of two or more atoms with a molecular weight of less than 900 Dalton. Socioeconomic concerns and health issues in terms of the prevalence of chronic diseases are prioritized around the world. This has resulted in the improvement in production facilities within the pharmaceutical sector, which has been fuelling the demand for active pharmaceutical ingredients (API).
While biologics are gradually making the presence felt, Small Molecule API continues to be the cornerstone of pharmaceutical development. Rise in demand for effective treatment for chronic disease in various therapeutic areas has been fuelling the demand for small molecule API.
In its new study, ESOMAR-certified market research and consulting firm Future Market Insights offers insights into key factors driving demand for Small Molecule API. The report tracks global sales of small molecule API in 20+ high-growth markets, where the maximum demand is witnessed in East Asia, followed by South Asia. Small molecule API are widely used in various chronic disease, but Oncology the dominant Production amongst all. The report also analyzes the impact COVID-19 has had on the pharmaceutical industry in general, and the small molecule API space in particular.
Let us know your requirement to get
100% FREE customization
How does the Historical and Future Outlook for Small Molecule API Market Compare?
In-House and outsourcing manufacturing of small molecule API continue to be hot topics in the pharmaceutical sector. The demand for outsource manufacturing in small molecule market has been on the rise because of increasing production cost and burden management. Subsequently, rising incidence of chronic diseases, besides investment in research and development (R&D) initiatives have been enabling growth.
Factors such as availability of several promising drug pipeline that have disease-modifying properties and a better safety and efficacy profile are attracting increasing number of players towards the market. As per FMI, the market exhibited a CAGR of 4.5% till 2020.
Current suboptimal growth of contract development and manufacturing organizations (CDMOs), advancements in small molecule (API) manufacturing, an increasing number of abbreviated new drug applications (ANDA), growth of healthcare market in Asia Pacific and other developing countries, expansion in terms of product offering, and reduction in operational cost are creating opportunities for growth in small molecule API market.
Increasing diagnosis of chronic diseases has bolstered the production of small molecule API. Increasing research on small molecule APIs will boost the Small Molecule API Market growth. Driven by above factors the market is expected to exhibit a CAGR of 5% through 2031.
The COVID-19 outbreak was unforeseen. It has changed the national healthcare priorities and spending. While the healthcare industry has been finding it increasingly difficult to accommodate the increasing burden of patients, it is considered to have a short-term impact on the small molecule API market. In first two quarter there was slow down in all segment of market due to lockdown and restrictions imposed on transport facilities.
Increase in government funding and polices favoring entry of startups in last two quarter of the year is creating growth opportunities. There is a rapid development in the technologies that are used for the long-term delivery of medications in molecule type. Spurred by this, the Small Molecule API Market will continue exhibiting steady growth through the forecast period.
How is Rising Incidence of Chronic Ailments affecting Small Molecule Market Growth?
API manufacturing has proven to be quiet effective in the last few years. Besides this, factors such as increasing incidence of cancer and subsequently rising demand for effective diagnosis and R&D in oncology therapeutic will fuel the demand for small molecule oncology therapy. Small molecule oncology drugs have proven effective in cancer treatment.
While biologics are making their presence felt in the pharmaceutical sector, small molecule API will continue accounting for majority of new drug application. It also constitute a significant share in the drug development pipeline. Core advantage of small molecules in delivering strong therapeutic benefits in smaller doses will remain a chief growth driver.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystCountry-wise Insights
How big is the Opportunity in China?
FMI has projected China to remain one of the most lucrative markets for small molecule API. It is expected to register a CAGR of over 5.5% during the forecast period. Besides increasing incidence of various illnesses, the China market is driven by expansion of API manufacturing units. Presence of less stringent policy in terms of waste product management will continue supporting growth in China.
Besides this, social determination and growing R&D facilities in the country will enhance the Small Molecule API Market growth. In addition, increasing focus on patient awareness and the presence of major players have catapulted China at the forefront of small molecule API manufacturing.
What are Prospects for Small Molecule API Manufacturing in Japan?
The per capita spending on medical care is increasing in Japan. Individuals' longing and capacity to spend on wellbeing has prompted a steady move in medical services consumption. In the course of the last few years, the worldwide per capita medical care spending has practically multiplied. Fast financial and populace development just as expanding extra cash are the superb components answerable for the development of the general medical care industry.
This has also helped in the expansion of the Small Molecule API Market in Japan. The presence of some of the leading players also has been supporting growth.
What is Driving Small Molecule API in India?
As per the India Brand Equity Foundation (IBEF), Indian pharmaceutical trade reached US$ 16.2 till 2020. Pharma vision 2020 will advance the pioneer in start to finish assembling of API. 100% FDI has been permitted for the programmed course for creation of API.
India holds a lucrative production globally in terms of pharmaceutical manufacturing. The nation likewise has an enormous pool of researchers and architects with a possibility to guide the business ahead to more prominent statures. By and by, more than 80% of the antiretroviral drugs utilized universally to battle Acquired Immune Deficiency Syndrome (AIDS) are provided by Indian drug firms.
Coupled with this, the World Health Organization (WHO) reported the setting up of the Global Center of Traditional Medicine in India. These factors are spurring pharmaceutical production in India, in turn fuelling the demand for small molecule API.
Rising Onychomycosis Cases Elevating Small Molecule API Demand in Germany
Germany will continue to dominating the small Molecule API market in Europe. It is expected to contribute over 30% of sales in the Europe market. The rising incidence of various ailments, together with increasing pharmaceutical spending has been fuelling demand in the country.
According to the World Bank, healthcare expenditure in Germany stood at above 11% of GDP in 2018. With prevailing trends indicating towards increasing spending, the investment in small API molecules is expected to increase.
Small Molecule API Market - Category-wise Insights
Which is the Leading Small Molecule API Type?
The Standard API will continue to hold maximum share in the global small molecule API market with a market share of over 79.6%.
Which is the Key Therapeutic Area for Small Molecule API?
Oncology accounts for 26.6% of the Small Molecule API Market share by therapeutic area. Small molecule API plays a crucial role in drug development for the treatment of cancer. According to the World Health Organization (WHO), cancer is the second-leading cause of death around the world. With the incidence forecast to rise further, the demand for small molecule API will surge in the coming years.
However, the introduction of combination drug and increment in R&D in drug development for the molecule type of oncology therapeutic area is expected to result in reduced sales of oncology drug induced Small Molecule API.
Why Does Commercial Application account for Greater Sales of Small Molecule API?
According to FMI, the demand for small molecule API will by highest in commercial use. The commercial segment will lead throughout the forecast period. The rising use of API in pharmaceutical manufacturing will continue enabling sales in the segment.
An unified Market Research Subscription Platform, built for today’s disparate research needs.
Small Molecule API Market - Competitive Landscape
Manufacturers in the small molecule API market are aiming to carry out strategic collaborations and R&D.
For instance In December 2020, Pfizer Inc. and Poster announced a strategic partnership with the goal of accelerating small molecule drug discovery by developing a platform technology based on generative chemistry.
In January 2020, acquisition of operations of Aspen in Japan. This acquisition strengthened Sandoz's position in world market of off-patent medicines and generic drugs.
In March 2021, U.S. Food and Drug Administration (FDA) has accepted New Drug Application for gefapixant, an orally administered for the Molecule Type of refractory chronic cough (RCC) in adults.
The company is strategically making promotional plans for its established prescription brands to increase their awareness within the prescription market Its ‘Get Old’ campaign also makes a frequent appearance on the main company feeds and through its own Twitter and Facebook page. Pfizer Inc. may be known for blockbuster prescription drug products such as Viagra and Lipitor, but the company is engaged in effective promotions to increase its brand recall among established prescription brands.
Some of the leading companies operating in the Small Molecule API Market are:
- Pfizer Inc.
- Johnson Matthey
- Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd.
- Sanofi S.A.
- Novartis AG,
- Bristol-Myers Squibb,
- Boehringer Ingelheim GmbH
- GlaxoSmithKline PLC
- GILEAD Science Inc.,
- Albany Molecular Research Inc.
- AstraZeneca
- Merck & Co, Inc.
- BASF SE
- Teva Pharmaceuticals
- Hoffmann-La Roche Ltd
Small Molecule API Market - Scope of Report
|
Attribute |
Details |
|
Small Molecule API Market Forecast Period |
2021-2031 |
|
Historical Data Available for |
2016-2020 |
|
Small Molecule API Market Analysis |
USD Million for value |
|
Small Molecule API Market Key Regions Covered |
North America, Latin America, Europe, East Asia, South Asia, Oceania and the Middle East & Africa |
|
Small Molecule API Market Key Countries Covered |
US, Canada, Germany, U.K., France, Italy, Spain, Poland, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Indonesia, Australia, New Zealand, GCC Countries, Turkey, Northern Africa and South Africa |
|
Small Molecule API Market Key Segments Covered |
Molecule Type, production , application, therapeutic area and Region |
|
Small Molecule API Market Key Companies Profiled |
|
|
Small Molecule API Market - Report Coverage |
Market Forecast, brand share analysis, competition Intelligence, DROT Analysis, Market Dynamics and Challenges and Strategic Growth Initiatives |
|
Customization & Pricing |
Small Molecule API Market by Category
Molecule Type:
- Standard API
- HPAPI
Production:
- Captive/In-House
- Out Source
Application:
- Clinical
- Commercial
Therapeutic Area:
- Cardiovascular Diseases
- Respiratory Disorders
- Infectious Diseases
- Metabolic Disorders
- Oncology
- Immunology
- Neurology
- Urology
- Dermatology
- Ophthalmology
- General Health
- Others
Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Middle East and Africa (MEA)
- Oceania
Frequently Asked Questions
East Asia currently holds for the largest share in the small molecule API market. According to FMI, it accounts for 35% of the global market share.
Oncology segment will continue to remain the leading therapeutic area driven by increasing demand for effective diagnosis and treatment of cancer.
Commercial application continues to account for maximum sales in small molecule API market.
Some of the leading companies operating in the Small Molecule API market are Teva Pharmaceutical Industries Ltd., Sanofi S.A., Pfizer Inc., Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd., Novartis AG, Bristol-Myers Squibb, Boehringer Ingelheim GmbH, GlaxoSmithKline PLC, GILEAD Science Inc., Albany Molecular Research Inc., AstraZeneca, Merck & Co, Inc., BASF SE, Hoffmann-La Roche Ltd
In-house and outsource are two major areas driving the sales of small molecule API. Of these, outsource is expected to lead the market.
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Drug Development Trends
4. Key Success Factors
4.1. API Drug Manufacturing / Usage Analysis
4.2. New API Drug Launches and Regulatory Approvals
4.3. Key Strategies Followed By Manufacturers
4.4. Regulatory Scenario
4.5. Key Promotional Strategies, By Manufacturers
5. Small Molecule API Market Demand (Size in US$ Mn) Analysis 2016-2020 and Forecast, 2021-2031
5.1. Historical Market Value (US$ Mn) Analysis, 2016-2020
5.2. Current and Future Market Value (US$ Mn) Projections, 2021-2031
5.2.1. Y-o-Y Growth Trend Analysis
5.2.2. Absolute $ Opportunity Analysis
6. Market Background
6.1. Macro-Economic Factors
6.1.1. Global GDP Growth Outlook
6.1.2. Per Capita Healthcare Expenditure Outlook
6.2. Forecast Factors - Relevance & Impact
6.2.1. API Drug Adoption Rate and Demand
6.2.1. New API Molecule Type Approvals and Launches
6.2.2. Rising R & D Funding
6.2.3. Increasing Application of API or Small Molecule Types
6.2.4. Regulatory Policies
6.2.5. Treatment Seeking Rate
6.3. Market Dynamics
6.3.1. Drivers
6.3.2. Restraints
6.3.3. Opportunity Analysis
6.4. COVID19 Crisis Analysis
6.4.1. Current COVID19 Statistics and Probable Future Impact
6.4.2. Current GDP Projection and Probable Impact
6.4.3. COVID19 and Impact Analysis
6.4.3.1. Revenue By Molecule Type
6.4.3.2. Revenue By Production
6.4.3.3. Revenue By Application
6.4.3.4. Revenue By Therapeutic Area
6.4.3.5. Revenue By Country
6.4.4. 2020 Market Scenario
6.4.5. Quarter by Quarter Forecast
6.4.6. Projected recovery Quarter
7. Global Small Molecule API Market Analysis 2016-2020 and Forecast 2021-2031, by Molecule Type
7.1. Introduction / Key Findings
7.2. Historical Market Size (US$ Mn) By Molecule Type, 2016-2020
7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Molecule Type, 2021-2031
7.3.1. Standard API
7.3.2. HPAPI
7.4. Market Attractiveness Analysis By Molecule Type
8. Global Small Molecule API Market Analysis 2016-2020 and Forecast 2021-2031, by Production
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) By Production, 2016-2020
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Production, 2021-2031
8.3.1. Captive/In-House
8.3.2. Out Source
8.4. Market Attractiveness Analysis By Production
9. Global Small Molecule API Market Analysis 2016-2020 and Forecast 2021-2031, by Application
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis By Application, 2016-2020
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2021-2031
9.3.1. Clinical
9.3.2. Commercial
9.4. Market Attractiveness Analysis By Application
10. Global Small Molecule API Market Analysis 2016-2020 and Forecast 2021-2031, by Therapeutic Area
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis By Therapeutic Area, 2016-2020
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Therapeutic Area, 2021-2031
10.3.1. Cardiovascular Diseases
10.3.2. Respiratory Disorders
10.3.3. Infectious Diseases
10.3.4. Metabolic Disorders
10.3.5. Oncology
10.3.6. Immunology
10.3.7. Neurology
10.3.8. Urology
10.3.9. Dermatology
10.3.10. Ophthalmology
10.3.11. General Health
10.3.12. Others
10.4. Market Attractiveness Analysis By Therapeutic Area
11. Global Small Molecule API Market Analysis 2016-2020 and Forecast 2021-2031, by Region
11.1. Introduction
11.2. Historical Market Size (US$ Mn) Analysis By Region, 2014 - 2018
11.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2020 - 2029
11.3.1. North America
11.3.2. Latin America
11.3.3. Europe
11.3.4. East Asia
11.3.5. South Asia
11.3.6. Oceania
11.3.7. Middle East and Africa (MEA)
11.4. Market Attractiveness Analysis By Region
12. North America Small Molecule API Market Analysis 2016-2020 and Forecast 2021-2031
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2016-2020
12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031
12.3.1. By Country
12.3.1.1. U.S.
12.3.1.2. Canada
12.3.2. By Molecule Type
12.3.3. By Production
12.3.4. By Application
12.3.5. By Therapeutic Area
12.4. Market Attractiveness Analysis
12.5. Key Market Participants - Intensity Mapping
12.6. Drivers and Restraints - Impact Analysis
13. Latin America Small Molecule API Market Analysis 2016-2020 and Forecast 2021-2031
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014 - 2018
13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031
13.3.1. By Country
13.3.1.1. Brazil
13.3.1.2. Mexico
13.3.1.3. Argentina
13.3.1.4. Rest of Latin America
13.3.2. By Molecule Type
13.3.3. By Production
13.3.4. By Application
13.3.5. By Therapeutic Area
13.4. Market Attractiveness Analysis
13.5. Key Market Participants - Intensity Mapping
13.6. Drivers and Restraints - Impact Analysis
14. Europe Small Molecule API Market Analysis 2016-2020 and Forecast 2021-2031
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2016-2020
14.3. Market Size (US$ Mn) Forecast By Market Taxonomy2021-2031
14.3.1. By Country
14.3.1.1. Germany
14.3.1.2. Italy
14.3.1.3. France
14.3.1.4. U.K.
14.3.1.5. Spain
14.3.1.6. BENELUX
14.3.1.7. Russia
14.3.1.8. Rest of Europe
14.3.2. By Molecule Type
14.3.3. By Production
14.3.4. By Application
14.3.5. By Therapeutic Area
14.4. Market Attractiveness Analysis
14.5. Key Market Participants - Intensity Mapping
14.6. Drivers and Restraints - Impact Analysis
15. South Asia Small Molecule API Market Analysis 2016-2020 and Forecast 2021-2031
15.1. Introduction
15.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2016-2020
15.3. Market Size (US$ Mn) Forecast By Market Taxonomy2021-2031
15.3.1. By Country
15.3.1.1. India
15.3.1.2. Thailand
15.3.1.3. Indonesia
15.3.1.4. Malaysia
15.3.1.5. Rest of South Asia
15.3.2. By Molecule Type
15.3.3. By Production
15.3.4. By Application
15.3.5. By Therapeutic Area
15.4. Market Attractiveness Analysis
15.5. Key Market Participants - Intensity Mapping
15.6. Drivers and Restraints - Impact Analysis
16. East Asia Small Molecule API Market Analysis 2016-2020 and Forecast 2021-2031
16.1. Introduction
16.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2016-2020
16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031
16.3.1. By Country
16.3.1.1. China
16.3.1.2. Japan
16.3.1.3. South Korea
16.3.2. By Molecule Type
16.3.3. By Production
16.3.4. By Application
16.3.5. By Therapeutic Area
16.4. Market Attractiveness Analysis
16.5. Key Market Participants - Intensity Mapping
16.6. Drivers and Restraints - Impact Analysis
17. Oceania Small Molecule API Market Analysis 2016-2020 and Forecast 2021-2031
17.1. Introduction
17.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2016-2020
17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031
17.3.1. By Country
17.3.1.1. Australia
17.3.1.2. New Zealand
17.3.2. By Molecule Type
17.3.3. By Production
17.3.4. By Application
17.3.5. By Therapeutic Area
17.4. Market Attractiveness Analysis
17.5. Key Market Participants - Intensity Mapping
17.6. Drivers and Restraints - Impact Analysis
18. Middle East and Africa Small Molecule API Market Analysis 2016-2020 and Forecast 2021-2031
18.1. Introduction
18.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2016-2020
18.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031
18.3.1. By Country
18.3.1.1. GCC Countries
18.3.1.2. Turkey
18.3.1.3. South Africa
18.3.1.4. Rest of Middle East and Africa
18.3.2. By Molecule Type
18.3.3. By Production
18.3.4. By Application
18.3.5. By Therapeutic Area
18.4. Market Attractiveness Analysis
18.5. Key Market Participants - Intensity Mapping
18.6. Drivers and Restraints - Impact Analysis
19. Key and Emerging Countries Small Molecule API Market Analysis 2016-2020 and Forecast 2021-2031
19.1. Introduction
19.1.1. Market Value Proportion Analysis, By Key Countries
19.1.2. Global Vs. Country Growth Comparison
19.2. U.S. Small Molecule API Market Analysis
19.2.1. By Molecule Type
19.2.2. By Production
19.2.3. By Application
19.2.4. By Therapeutic Area
19.3. Canada Small Molecule API Market Analysis
19.3.1. By Molecule Type
19.3.2. By Production
19.3.3. By Application
19.3.4. By Therapeutic Area
19.4. Mexico Small Molecule API Market Analysis
19.4.1. By Molecule Type
19.4.2. By Production
19.4.3. By Application
19.4.4. By Therapeutic Area
19.5. Brazil Small Molecule API Market Analysis
19.5.1. By Molecule Type
19.5.2. By Production
19.5.3. By Application
19.5.4. By Therapeutic Area
19.6. U.K. Small Molecule API Market Analysis
19.6.1. By Molecule Type
19.6.2. By Production
19.6.3. By Application
19.6.4. By Therapeutic Area
19.7. Germany Small Molecule API Market Analysis
19.7.1. By Molecule Type
19.7.2. By Production
19.7.3. By Application
19.7.4. By Therapeutic Area
19.8. France Small Molecule API Market Analysis
19.8.1. By Molecule Type
19.8.2. By Production
19.8.3. By Application
19.8.4. By Therapeutic Area
19.9. Italy Small Molecule API Market Analysis
19.9.1. By Molecule Type
19.9.2. By Production
19.9.3. By Application
19.9.4. By Therapeutic Area
19.10. Spain Small Molecule API Market Analysis
19.10.1. By Molecule Type
19.10.2. By Production
19.10.3. By Application
19.10.4. By Therapeutic Area
19.11. BENELUX Small Molecule API Market Analysis
19.11.1. By Molecule Type
19.11.2. By Production
19.11.3. By Application
19.11.4. By Therapeutic Area
19.12. Russia Small Molecule API Market Analysis
19.12.1. By Molecule Type
19.12.2. By Production
19.12.3. By Application
19.12.4. By Therapeutic Area
19.13. China Small Molecule API Market Analysis
19.13.1. By Molecule Type
19.13.2. By Production
19.13.3. By Application
19.13.4. By Therapeutic Area
19.14. Japan Small Molecule API Market Analysis
19.14.1. By Molecule Type
19.14.2. By Production
19.14.3. By Application
19.14.4. By Therapeutic Area
19.15. South Korea Small Molecule API Market Analysis
19.15.1. By Molecule Type
19.15.2. By Production
19.15.3. By Application
19.15.4. By Therapeutic Area
19.16. India Small Molecule API Market Analysis
19.16.1. By Molecule Type
19.16.2. By Production
19.16.3. By Application
19.16.4. By Therapeutic Area
19.17. ASEAN Small Molecule API Market Analysis
19.17.1. By Molecule Type
19.17.2. By Production
19.17.3. By Application
19.17.4. By Therapeutic Area
19.18. Australia Small Molecule API Market Analysis
19.18.1. By Molecule Type
19.18.2. By Production
19.18.3. By Application
19.18.4. By Therapeutic Area
19.19. New Zealand Small Molecule API Market Analysis
19.19.1. By Molecule Type
19.19.2. By Production
19.19.3. By Application
19.19.4. By Therapeutic Area
19.20. GCC Countries Small Molecule API Market Analysis
19.20.1. By Molecule Type
19.20.2. By Production
19.20.3. By Application
19.20.4. By Therapeutic Area
19.21. Turkey Small Molecule API Market Analysis
19.21.1. By Molecule Type
19.21.2. By Production
19.21.3. By Application
19.21.4. By Therapeutic Area
19.22. South Africa Small Molecule API Market Analysis
19.22.1. By Molecule Type
19.22.2. By Production
19.22.3. By Application
19.22.4. By Therapeutic Area
20. Market Structure Analysis
20.1. Market Analysis by Tier of Companies
20.2. Market Concentration
20.3. Market Share Analysis of Top Players
20.4. Market Presence Analysis
20.4.1. By Regional footprint of Players
20.4.2. Product foot print by Players
20.4.3. Channel Foot Print by Players
21. Competition Analysis
21.1. Competition Dashboard
21.2. Competition Benchmarking
21.3. Competition Deep Dive
21.3.1. Johnson Matthey
21.3.1.1. Overview
21.3.1.2. Product Portfolio
21.3.1.3. Profitability by Market Segments (Product/Channel/Region)
21.3.1.4. Sales Footprint
21.3.1.5. Strategy Overview
21.3.1.5.1. Marketing Strategy
21.3.1.5.2. Product Strategy
21.3.1.5.3. Channel Strategy
21.3.2. Pfizer Inc.
21.3.2.1. Overview
21.3.2.2. Product Portfolio
21.3.2.3. Profitability by Market Segments (Product/Channel/Region)
21.3.2.4. Sales Footprint
21.3.2.5. Strategy Overview
21.3.2.5.1. Marketing Strategy
21.3.2.5.2. Product Strategy
21.3.2.5.3. Channel Strategy
21.3.3. Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd.
21.3.3.1. Overview
21.3.3.2. Product Portfolio
21.3.3.3. Profitability by Market Segments (Product/Channel/Region)
21.3.3.4. Sales Footprint
21.3.3.5. Strategy Overview
21.3.3.5.1. Marketing Strategy
21.3.3.5.2. Product Strategy
21.3.3.5.3. Channel Strategy
21.3.4. Sanofi S.A.
21.3.4.1. Overview
21.3.4.2. Product Portfolio
21.3.4.3. Profitability by Market Segments (Product/Channel/Region)
21.3.4.4. Sales Footprint
21.3.4.5. Strategy Overview
21.3.4.5.1. Marketing Strategy
21.3.4.5.2. Product Strategy
21.3.4.5.3. Channel Strategy
21.3.5. Novartis AG,
21.3.5.1. Overview
21.3.5.2. Product Portfolio
21.3.5.3. Profitability by Market Segments (Product/Channel/Region)
21.3.5.4. Sales Footprint
21.3.5.5. Strategy Overview
21.3.5.5.1. Marketing Strategy
21.3.5.5.2. Product Strategy
21.3.5.5.3. Channel Strategy
21.3.6. Bristol-Myers Squibb,
21.3.6.1. Overview
21.3.6.2. Product Portfolio
21.3.6.3. Profitability by Market Segments (Product/Channel/Region)
21.3.6.4. Sales Footprint
21.3.6.5. Strategy Overview
21.3.6.5.1. Marketing Strategy
21.3.6.5.2. Product Strategy
21.3.6.5.3. Channel Strategy
21.3.7. Boehringer Ingelheim GmbH
21.3.7.1. Overview
21.3.7.2. Product Portfolio
21.3.7.3. Profitability by Market Segments (Product/Channel/Region)
21.3.7.4. Sales Footprint
21.3.7.5. Strategy Overview
21.3.7.5.1. Marketing Strategy
21.3.7.5.2. Product Strategy
21.3.7.5.3. Channel Strategy
21.3.8. GlaxoSmithKline PLC
21.3.8.1. Overview
21.3.8.2. Product Portfolio
21.3.8.3. Profitability by Market Segments (Product/Channel/Region)
21.3.8.4. Sales Footprint
21.3.8.5. Strategy Overview
21.3.8.5.1. Marketing Strategy
21.3.8.5.2. Product Strategy
21.3.8.5.3. Channel Strategy
21.3.9. GILEAD Science Inc.
21.3.9.1. Overview
21.3.9.2. Product Portfolio
21.3.9.3. Profitability by Market Segments (Product/Channel/Region)
21.3.9.4. Sales Footprint
21.3.9.5. Strategy Overview
21.3.9.5.1. Marketing Strategy
21.3.9.5.2. Product Strategy
21.3.9.5.3. Channel Strategy
21.3.10. Albany Molecular Research Inc.
21.3.10.1. Overview
21.3.10.2. Product Portfolio
21.3.10.3. Profitability by Market Segments (Product/Channel/Region)
21.3.10.4. Sales Footprint
21.3.10.5. Strategy Overview
21.3.10.5.1. Marketing Strategy
21.3.10.5.2. Product Strategy
21.3.10.5.3. Channel Strategy
21.3.11. AstraZeneca
21.3.11.1. Overview
21.3.11.2. Product Portfolio
21.3.11.3. Profitability by Market Segments (Product/Channel/Region)
21.3.11.4. Sales Footprint
21.3.11.5. Strategy Overview
21.3.11.5.1. Marketing Strategy
21.3.11.5.2. Product Strategy
21.3.11.5.3. Channel Strategy
21.3.12. Merck & Co, Inc.
21.3.12.1. Overview
21.3.12.2. Product Portfolio
21.3.12.3. Profitability by Market Segments (Product/Channel/Region)
21.3.12.4. Sales Footprint
21.3.12.5. Strategy Overview
21.3.12.5.1. Marketing Strategy
21.3.12.5.2. Product Strategy
21.3.12.5.3. Channel Strategy
21.3.13. BASF SE
21.3.13.1. Overview
21.3.13.2. Product Portfolio
21.3.13.3. Profitability by Market Segments (Product/Channel/Region)
21.3.13.4. Sales Footprint
21.3.13.5. Strategy Overview
21.3.13.5.1. Marketing Strategy
21.3.13.5.2. Product Strategy
21.3.13.5.3. Channel Strategy
21.3.14. Teva Pharmaceuticals
21.3.14.1. Overview
21.3.14.2. Product Portfolio
21.3.14.3. Profitability by Market Segments (Product/Channel/Region)
21.3.14.4. Sales Footprint
21.3.14.5. Strategy Overview
21.3.14.5.1. Marketing Strategy
21.3.14.5.2. Product Strategy
21.3.14.5.3. Channel Strategy
21.3.15. Hoffmann-La Roche Ltd
21.3.15.1. Overview
21.3.15.2. Product Portfolio
21.3.15.3. Profitability by Market Segments (Product/Channel/Region)
21.3.15.4. Sales Footprint
21.3.15.5. Strategy Overview
21.3.15.5.1. Marketing Strategy
21.3.15.5.2. Product Strategy
21.3.15.5.3. Channel Strategy
22. Assumptions and Acronyms Used
23. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 01: Global Small Molecules Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Molecule
Table 02: Global Small Molecules Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Production
Table 03: Global Small Molecules Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Application
Table 04: Global Small Molecules Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Therapeutic Area
Table 05: Global Small Molecules Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Region
Table 06: North America Small Molecules Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Molecule
Table 07: North America Small Molecules Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Production
Table 08: North America Small Molecules Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Application
Table 09: North America Small Molecules Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Therapeutic Area
Table 10: North America Small Molecules Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
Table 11: Latin America Small Molecules Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Molecule
Table 12: Latin America Small Molecules Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Production
Table 13: Latin America Small Molecules Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Application
Table 14: Latin America Small Molecules Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Therapeutic Area
Table 15: Latin America Small Molecules Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
Table 16: Europe America Small Molecules Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Molecule
Table 17: Europe America Small Molecules Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Production
Table 18: Europe America Small Molecules Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Application
Table 19: Europe America Small Molecules Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Therapeutic Area
Table 20: Europe America Small Molecules Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
Table 21: South Asia America Small Molecules Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Molecule
Table 22: South Asia America Small Molecules Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Production
Table 23: South Asia America Small Molecules Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Application
Table 24: South Asia America Small Molecules Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Therapeutic Area
Table 25: South Asia America Small Molecules Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
Table 26: East Asia America Small Molecules Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Molecule
Table 27: East Asia America Small Molecules Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Production
Table 28: East Asia America Small Molecules Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Application
Table 28: MEA America Small Molecules Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Application
Table 29: East Asia America Small Molecules Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Therapeutic Area
Table 30: East Asia America Small Molecules Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
Table 31: Oceania America Small Molecules Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Molecule
Table 32: Oceania America Small Molecules Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Production
Table 33: Oceania America Small Molecules Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Application
Table 34: Oceania America Small Molecules Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Therapeutic Area
Table 35: Oceania America Small Molecules Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
Table 36: MEA America Small Molecules Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Molecule
Table 37: MEA America Small Molecules Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Production
Table 39: MEA America Small Molecules Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Therapeutic Area
Table 40: MEA America Small Molecules Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 01: Global Small molecule Treatment Market Historical Market Value and Y-o-Y, 2016-2020
Figure 02: Global Small molecule Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2021-2031
Figure 03: Global Small molecule Treatment Market Absolute $ Opportunity, 2020 –2031
Figure 04: Global Small Molecules Market Historical Market Value (US$ Mn) Analysis, 2016-2020
Figure 05: Global Small Molecules Current and Future Market Value (US$ Mn), 2021-2031 & Y-o-Y Growth Trend
Figure 06: Global Small Molecules Market Share Analysis (%) By Molecule, 2020 & 2031
Figure 07: Global Small Molecules Market Y-o-Y Growth (%) By Molecule, 2021-2031
Figure 08: Global Small Molecules Market Attractiveness Analysis, By Molecule
Figure 09: Global Small Molecules Market Share Analysis (%) By Production, 2020 & 2031
Figure 10: Global Small Molecules Market Y-o-Y Growth (%) By Production, 2021-2031
Figure 11: Global Small Molecules Market Attractiveness Analysis, By Molecule
Figure 12: Global Small Molecules Market Share Analysis (%) By Application, 2020 & 2031
Figure 13: Global Small Molecules Market Y-o-Y Growth (%) By Application, 2021-2031
Figure 14: Global Small Molecules Market Attractiveness Analysis, By Application
Figure 15: Global Small Molecules Market Share Analysis (%) By Therapeutic Area, 2020 & 2031
Figure 16: Global Small Molecules Market Y-o-Y Growth (%) By Therapeutic Area, 2021-2031
Figure 17: Global Small Molecules Market Attractiveness Analysis, By Therapeutic Area
Figure 18: Global Small Molecules Market Share Analysis (%) By Region, 2020 & 2031
Figure 19: Global Small Molecules Market Y-o-Y Growth (%) By Region, 2021-2031
Figure 20: Global Small Molecules Market Attractiveness Analysis, By Region
Figure 21: North America Small Molecule API Market Share, By Country (2020)
Figure 22: North America Small Molecule API Market Share, By Molecule (2020)
Figure 23: North America Small Molecule API Market Share, By Production (2020)
Figure 24: North America Small Molecule API Market Share, By Application (2020)
Figure 25: North America Small Molecule API Market Share, By Therapeutic Area (2020)
Figure 26: North America Small Molecules Market Value (US$ Mn) Analysis, 2016–2020
Figure 27: North America Small Molecules Market Value (US$ Mn) & Y-o-Y Growth (%), 2020-2031
Figure 28: North America Small Molecules Market Attractiveness Analysis, By Molecule
Figure 29: North America Small Molecules Market Attractiveness Analysis, By Production
Figure 30: North America Small Molecules Market Attractiveness Analysis, By Application
Figure 31: North America Small Molecules Market Attractiveness Analysis, By Country
Figure 32: North America Small Molecules Market Attractiveness Analysis, By Production
Figure 33: Latin America Small Molecule API Market Share, By Country (2020)
Figure 34: Latin America Small Molecule API Market Share, By Molecule (2020)
Figure 35: Latin America Small Molecule API Market Share, By Production (2020)
Figure 36: Latin America Small Molecule API Market Share, By Application (2020)
Figure 37: Latin America Small Molecule API Market Share, By Therapeutic Area (2020)
Figure 38: Latin America Small Molecules Market Value (US$ Mn) Analysis, 2016–2020
Figure 39: Latin America Small Molecules Market Value (US$ Mn) & Y-o-Y Growth (%), 2020-2031
Figure 40: Latin America Small Molecules Market Attractiveness Analysis, By Molecule
Figure 41: Latin America Small Molecules Market Attractiveness Analysis, By Production
Figure 42: Latin America Small Molecules Market Attractiveness Analysis, By Application
Figure 43: Latin America Small Molecules Market Attractiveness Analysis, By Country
Figure 44: Latin America Small Molecules Market Attractiveness Analysis, By Therapeutic area
Figure 45: Europe America Small Molecule API Market Share, By Country (2020)
Figure 46: Europe America Small Molecule API Market Share, By Molecule (2020)
Figure 47: Europe America Small Molecule API Market Share, By Production (2020)
Figure 48: Europe America Small Molecule API Market Share, By Application (2020)
Figure 49: Europe America Small Molecule API Market Share, By Therapeutic Area (2020)
Figure 50: Europe Small Molecules Market Value (US$ Mn) Analysis, 2016–2020
Figure 51: Europe Small Molecules Market Value (US$ Mn) & Y-o-Y Growth (%), 2020-2031
Figure 52: Europe America Small Molecules Market Attractiveness Analysis, By Molecule
Figure 53: Europe America Small Molecules Market Attractiveness Analysis, By Production
Figure 54: Europe America Small Molecules Market Attractiveness Analysis, By Application
Figure 55: Europe America Small Molecules Market Attractiveness Analysis, By Country
Figure 56: Europe America Small Molecules Market Attractiveness Analysis, By Therapeutic area
Figure 57: South Asia America Small Molecule API Market Share, By Country (2020)
Figure 58: South Asia America Small Molecule API Market Share, By Molecule (2020)
Figure 59: South Asia America Small Molecule API Market Share, By Production (2020)
Figure 60: South Asia America Small Molecule API Market Share, By Application (2020)
Figure 61: South Asia America Small Molecule API Market Share, By Therapeutic Area (2020)
Figure 62: South Asia Small Molecules Market Value (US$ Mn) Analysis, 2016–2020
Figure 63: South Asia Small Molecules Market Value (US$ Mn) & Y-o-Y Growth (%), 2020-2031
Figure 64: South Asia America Small Molecules Market Attractiveness Analysis, By Molecule
Figure 65: South Asia America Small Molecules Market Attractiveness Analysis, By Production
Figure 66: South Asia America Small Molecules Market Attractiveness Analysis, By Application
Figure 67: South Asia America Small Molecules Market Attractiveness Analysis, By Country
Figure 68: South Asia America Small Molecules Market Attractiveness Analysis, By Therapeutic area
Figure 69: East Asia America Small Molecule API Market Share, By Country (2020)
Figure 70: East Asia America Small Molecule API Market Share, By Molecule (2020)
Figure 71: East Asia America Small Molecule API Market Share, By Production (2020)
Figure 72: East Asia America Small Molecule API Market Share, By Application (2020)
Figure 73: East Asia America Small Molecule API Market Share, By Therapeutic Area (2020)
Figure 74: East Asia Small Molecules Market Value (US$ Mn) Analysis, 2016–2020
Figure 75: East Asia Small Molecules Market Value (US$ Mn) & Y-o-Y Growth (%), 2020-2031
Figure 76: East Asia America Small Molecules Market Attractiveness Analysis, By Molecule
Figure 77: East Asia America Small Molecules Market Attractiveness Analysis, By Production
Figure 78: East Asia America Small Molecules Market Attractiveness Analysis, By Application
Figure 79: East Asia America Small Molecules Market Attractiveness Analysis, By Country
Figure 80: East Asia America Small Molecules Market Attractiveness Analysis, By Therapeutic area
Figure 81: Oceania America Small Molecule API Market Share, By Country (2020)
Figure 82: Oceania America Small Molecule API Market Share, By Molecule (2020)
Figure 83: Oceania America Small Molecule API Market Share, By Production (2020)
Figure 84: Oceania America Small Molecule API Market Share, By Application (2020)
Figure 85: Oceania America Small Molecule API Market Share, By Therapeutic Area (2020)
Figure 86: Oceania Small Molecules Market Value (US$ Mn) Analysis, 2016–2020
Figure 87: Oceania Small Molecules Market Value (US$ Mn) & Y-o-Y Growth (%), 2020-2031
Figure 88: Oceania America Small Molecules Market Attractiveness Analysis, By Molecule
Figure 89: Oceania America Small Molecules Market Attractiveness Analysis, By Production
Figure 90: Oceania America Small Molecules Market Attractiveness Analysis, By Application
Figure 91: Oceania America Small Molecules Market Attractiveness Analysis, By Country
Figure 92: Oceania America Small Molecules Market Attractiveness Analysis, By Therapeutic area
Figure 93: MEA America Small Molecule API Market Share, By Country (2020)
Figure 94: MEA America Small Molecule API Market Share, By Molecule (2020)
Figure 95: MEA America Small Molecule API Market Share, By Production (2020)
Figure 96: MEA America Small Molecule API Market Share, By Application (2020)
Figure 97: MEA America Small Molecule API Market Share, By Therapeutic Area (2020)
Figure 98: MEA Small Molecules Market Value (US$ Mn) Analysis, 2016–2020
Figure 99: MEA Small Molecules Market Value (US$ Mn) & Y-o-Y Growth (%), 2020-2031
Figure 100: MEA America Small Molecules Market Attractiveness Analysis, By Molecule
Figure 101: MEA America Small Molecules Market Attractiveness Analysis, By Production
Figure 102: MEA America Small Molecules Market Attractiveness Analysis, By Application
Figure 103: MEA America Small Molecules Market Attractiveness Analysis, By Country
Figure 104: MEA America Small Molecules Market Attractiveness Analysis, By Therapeutic area
Figure 105: U.S. Small Molecule API Market Share Analysis (%), by Molecule, 2021 & 2031
Figure 106: U.S. Small Molecule API Market Share Analysis (%), by Production, 2021 & 2031
Figure 107: U.S. Small Molecule API Market Share Analysis (%), by Application, 2021 & 2031
Figure 108: U.S. Small Molecule API Market Share Analysis (%), by Therapeutic Area, 2020 & 2031
Figure 109: U.S. Small Molecule API Market Value Analysis (US$ Mn), 2020 & 2031
Figure 110: Canada Small Molecule API Market Share Analysis (%), by Molecule, 2021 & 2031
Figure 111: Canada Small Molecule API Market Share Analysis (%), by Production, 2021 & 2031
Figure 112: Canada Small Molecule API Market Share Analysis (%), by Application, 2021 & 2031
Figure 113: Canada Small Molecule API Market Share Analysis (%), by Therapeutic Area, 2020 & 2031
Figure 114: Canada Small Molecule API Market Value Analysis (US$ Mn), 2020 & 2031
Figure 115: Brazil Small Molecule API Market Share Analysis (%), by Molecule, 2021 & 2031
Figure 116: Brazil Small Molecule API Market Share Analysis (%), by Production, 2021 & 2031
Figure 117: Brazil Small Molecule API Market Share Analysis (%), by Application, 2021 & 2031
Figure 118: Brazil Small Molecule API Market Share Analysis (%), by Therapeutic Area, 2020 & 2031
Figure 119: Brazil Small Molecule API Market Value Analysis (US$ Mn), 2020 & 2031
Figure 120: Mexico Small Molecule API Market Share Analysis (%), by Molecule, 2021 & 2031
Figure 121: Mexico Small Molecule API Market Share Analysis (%), by Production, 2021 & 2031
Figure 122: Mexico Small Molecule API Market Share Analysis (%), by Application, 2021 & 2031
Figure 123: Mexico Small Molecule API Market Share Analysis (%), by Therapeutic Area, 2020 & 2031
Figure 124: Mexico Small Molecule API Market Value Analysis (US$ Mn), 2020 & 2031
Figure 125: Argentina Small Molecule API Market Share Analysis (%), by Molecule, 2021 & 2031
Figure 126: Argentina Small Molecule API Market Share Analysis (%), by Production, 2021 & 2031
Figure 127: Argentina Small Molecule API Market Share Analysis (%), by Application, 2021 & 2031
Figure 128: Argentina Small Molecule API Market Share Analysis (%), by Therapeutic Area, 2020 & 2031
Figure 129: Argentina Small Molecule API Market Value Analysis (US$ Mn), 2020 & 2031
Figure 130: Germany Small Molecule API Market Share Analysis (%), by Molecule, 2021 & 2031
Figure 131: Germany Small Molecule API Market Share Analysis (%), by Production, 2021 & 2031
Figure 132: Germany Small Molecule API Market Share Analysis (%), by Application, 2021 & 2031
Figure 133: Germany Small Molecule API Market Share Analysis (%), by Therapeutic Area, 2020 & 2031
Figure 134: Germany Small Molecule API Market Value Analysis (US$ Mn), 2020 & 2031
Figure 135: U.K Small Molecule API Market Share Analysis (%), by Molecule, 2021 & 2031
Figure 136: U.K Small Molecule API Market Share Analysis (%), by Production, 2021 & 2031
Figure 137: U.K Small Molecule API Market Share Analysis (%), by Application, 2021 & 2031
Figure 138: U.K Small Molecule API Market Share Analysis (%), by Therapeutic Area, 2020 & 2031
Figure 139: U.K Small Molecule API Market Value Analysis (US$ Mn), 2020 & 2031
Figure 140: France Small Molecule API Market Share Analysis (%), by Molecule, 2021 & 2031
Figure 141: France Small Molecule API Market Share Analysis (%), by Production, 2021 & 2031
Figure 142: France Small Molecule API Market Share Analysis (%), by Application, 2021 & 2031
Figure 143: France Small Molecule API Market Share Analysis (%), by Therapeutic Area, 2020 & 2031
Figure 144: France Small Molecule API Market Value Analysis (US$ Mn), 2020 & 2031
Figure 145: Italy Small Molecule API Market Share Analysis (%), by Molecule, 2021 & 2031
Figure 146: Italy Small Molecule API Market Share Analysis (%), by Production, 2021 & 2031
Figure 147: Italy Small Molecule API Market Share Analysis (%), by Application, 2021 & 2031
Figure 148: Italy Small Molecule API Market Share Analysis (%), by Therapeutic Area, 2020 & 2031
Figure 149: Italy Small Molecule API Market Value Analysis (US$ Mn), 2020 & 2031
Figure 150: Nordic Small Molecule API Market Share Analysis (%), by Molecule, 2021 & 2031
Figure 151: Nordic Small Molecule API Market Share Analysis (%), by Production, 2021 & 2031
Figure 152: Nordic Small Molecule API Market Share Analysis (%), by Application, 2021 & 2031
Figure 153: Nordic Small Molecule API Market Share Analysis (%), by Therapeutic Area, 2020 & 2031
Figure 154: Nordic Small Molecule API Market Value Analysis (US$ Mn), 2020 & 2031
Figure 155: Benelux Small Molecule API Market Share Analysis (%), by Molecule, 2021 & 2031
Figure 156: Benelux Small Molecule API Market Share Analysis (%), by Production, 2021 & 2031
Figure 157: Benelux Small Molecule API Market Share Analysis (%), by Application, 2021 & 2031
Figure 158: Benelux Small Molecule API Market Share Analysis (%), by Therapeutic Area, 2020 & 2031
Figure 159: Benelux Small Molecule API Market Value Analysis (US$ Mn), 2020 & 2031
Figure 160: Spain Small Molecule API Market Share Analysis (%), by Molecule, 2021 & 2031
Figure 161: Spain Small Molecule API Market Share Analysis (%), by Production, 2021 & 2031
Figure 162: Spain Small Molecule API Market Share Analysis (%), by Application, 2021 & 2031
Figure 163: Spain Small Molecule API Market Share Analysis (%), by Therapeutic Area, 2020 & 2031
Figure 164: Spain Small Molecule API Market Value Analysis (US$ Mn), 2020 & 2031
Figure 165: Poland Small Molecule API Market Share Analysis (%), by Molecule, 2021 & 2031
Figure 166: Poland Small Molecule API Market Share Analysis (%), by Production, 2021 & 2031
Figure 167: Poland Small Molecule API Market Share Analysis (%), by Application, 2021 & 2031
Figure 168: Poland Small Molecule API Market Share Analysis (%), by Therapeutic Area, 2021 & 2031
Figure 169: Poland Small Molecule API Market Value Analysis (US$ Mn), 2021 & 2031
Figure 170: Russia Small Molecule API Market Share Analysis (%), by Molecule, 2021 & 2031
Figure 171: Russia Small Molecule API Market Share Analysis (%), by Production, 2021 & 2031
Figure 172: Russia Small Molecule API Market Share Analysis (%), by Application, 2021 & 2031
Figure 173: Russia Small Molecule API Market Share Analysis (%), by Therapeutic Area, 2020 & 2031
Figure 174: Russia Small Molecule API Market Value Analysis (US$ Mn), 2020 & 2031
Figure 175: China Small Molecule API Market Share Analysis (%), by Molecule, 2021 & 2031
Figure 176: China Small Molecule API Market Share Analysis (%), by Production, 2021 & 2031
Figure 177: China Small Molecule API Market Share Analysis (%), by Application, 2021 & 2031
Figure 178: China Small Molecule API Market Share Analysis (%), by Therapeutic Area, 2020 & 2031
Figure 179: China Small Molecule API Market Value Analysis (US$ Mn), 2020 & 2031
Figure 180: Japan Small Molecule API Market Share Analysis (%), by Molecule, 2021 & 2031
Figure 181: Japan Small Molecule API Market Share Analysis (%), by Production, 2021 & 2031
Figure 182: Japan Small Molecule API Market Share Analysis (%), by Application, 2021 & 2031
Figure 183: Japan Small Molecule API Market Share Analysis (%), by Therapeutic Area, 2020 & 2031
Figure 184: Japan Small Molecule API Market Value Analysis (US$ Mn), 2020 & 2031
Figure 185: South Korea Small Molecule API Market Share Analysis (%), by Molecule, 2021 & 2031
Figure 186: South Korea Small Molecule API Market Share Analysis (%), by Production, 2021 & 2031
Figure 187: South Korea Small Molecule API Market Share Analysis (%), by Application, 2021 & 2031
Figure 188: South Korea Small Molecule API Market Share Analysis (%), by Therapeutic Area, 2020 & 2031
Figure 189: South Korea Small Molecule API Market Value Analysis (US$ Mn), 2020 & 2031
Figure 190: India Small Molecule API Market Share Analysis (%), by Molecule, 2021 & 2031
Figure 191: India Small Molecule API Market Share Analysis (%), by Production, 2021 & 2031
Figure 192: India Small Molecule API Market Share Analysis (%), by Application, 2021 & 2031
Figure 193: India Small Molecule API Market Share Analysis (%), by Therapeutic Area, 2020 & 2031
Figure 194: India Small Molecule API Market Value Analysis (US$ Mn), 2020 & 2031
Figure 195: Thailand Small Molecule API Market Share Analysis (%), by Molecule, 2021 & 2031
Figure 196: Thailand Small Molecule API Market Share Analysis (%), by Production, 2021 & 2031
Figure 197: Thailand Small Molecule API Market Share Analysis (%), by Application, 2021 & 2031
Figure 198: Thailand Small Molecule API Market Share Analysis (%), by Therapeutic Area, 2020 & 2031
Figure 199: Thailand Small Molecule API Market Value Analysis (US$ Mn), 2020 & 2031
Figure 200: Malaysia Small Molecule API Market Share Analysis (%), by Molecule, 2021 & 2031
Figure 201: Malaysia Small Molecule API Market Share Analysis (%), by Production, 2021 & 2031
Figure 202: Malaysia Small Molecule API Market Share Analysis (%), by Application, 2021 & 2031
Figure 203: Malaysia Small Molecule API Market Share Analysis (%), by Therapeutic Area, 2020 & 2031
Figure 204: Malaysian Small Molecule API Market Value Analysis (US$ Mn), 2020 & 2031
Figure 205: Indonesia Small Molecule API Market Share Analysis (%), by Molecule, 2021 & 2031
Figure 206: Indonesia Small Molecule API Market Share Analysis (%), by Production, 2021 & 2031
Figure 207: Indonesia Small Molecule API Market Share Analysis (%), by Application, 2021 & 2031
Figure 208: Indonesia Small Molecule API Market Share Analysis (%), by Therapeutic Area, 2020 & 2031
Figure 209: Indonesia Small Molecule API Market Value Analysis (US$ Mn), 2020 & 2031
Figure 210: Australia Small Molecule API Market Share Analysis (%), by Molecule, 2021 & 2031
Figure 211: Australia Small Molecule API Market Share Analysis (%), by Production, 2021 & 2031
Figure 212: Australia Small Molecule API Market Share Analysis (%), by Application, 2021 & 2031
Figure 213: Australia Small Molecule API Market Share Analysis (%), by Therapeutic Area, 2020 & 2031
Figure 214: Australia Small Molecule API Market Value Analysis (US$ Mn), 2020 & 2031
Figure 215: New Zealand Small Molecule API Market Share Analysis (%), by Molecule, 2021 & 2031
Figure 216: New Zealand Small Molecule API Market Share Analysis (%), by Production, 2021 & 2031
Figure 217: New Zealand Small Molecule API Market Share Analysis (%), by Application, 2021 & 2031
Figure 218: New Zealand Small Molecule API Market Share Analysis (%), by Therapeutic Area, 2020 & 2031
Figure 219: New Zealand Small Molecule API Market Value Analysis (US$ Mn), 2020 & 2031
Figure 220: GCC Countries Small Molecule API Market Share Analysis (%), by Molecule, 2021 & 2031
Figure 221: GCC Countries Small Molecule API Market Share Analysis (%), by Production, 2021 & 2031
Figure 222: GCC Countries Small Molecule API Market Share Analysis (%), by Application, 2021 & 2031
Figure 223: GCC Countries Small Molecule API Market Share Analysis (%), by Therapeutic Area, 2020 & 2031
Figure 224: GCC Countries Small Molecule API Market Value Analysis (US$ Mn), 2020 & 2031
Figure 225: South Africa Small Molecule API Market Share Analysis (%), by Molecule, 2021 & 2031
Figure 226: South Africa Small Molecule API Market Share Analysis (%), by Production, 2021 & 2031
Figure 227: South Africa Small Molecule API Market Share Analysis (%), by Application, 2021 & 2031
Figure 228: South Africa Small Molecule API Market Share Analysis (%), by Therapeutic Area, 2020 & 2031
Figure 229: South Africa Small Molecule API Market Value Analysis (US$ Mn), 2020 & 2031
Figure 230: North Africa Small Molecule API Market Share Analysis (%), by Molecule, 2021 & 2031
Figure 231: North Africa Small Molecule API Market Share Analysis (%), by Production, 2021 & 2031
Figure 232: North Africa Small Molecule API Market Share Analysis (%), by Application, 2021 & 2031
Figure 233: North Africa Small Molecule API Market Share Analysis (%), by Therapeutic Area, 2020 & 2031
Figure 234: North Africa Small Molecule API Market Value Analysis (US$ Mn), 2020 & 2031
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
